Cheaper alternative to EpiPen allergy shot approved by FDA

From the Verge:

800.0The US Food and Drug Administration has approved a new allergy shot medication that will directly compete with Mylan’s EpiPen, the allergy medicine that’s been heavily criticized for being unaffordable. It’s not clear how much the new medication will cost, but manufacturer Adamis Pharmaceuticals Corporation says it’ll be a cheaper alternative to the EpiPen.

Called Symjepi, the new allergy shot also comes in two, single-dose syringes filled with the hormone epinephrine, which ends potentially life-threatening allergy attacks from bug bites, foods like nuts, and other medication. Symjepi is expected to hit the market later this year, according to the Associated Press.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: